Video

Dr. Abedin on the Need for Risk Stratification Before Chemoimmunotherapy in CLL

Sameem Abedin, MD, discusses the need for risk stratification prior to giving chemoimmunotherapy to patients with chronic lymphocytic leukemia.

Sameem Abedin, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, discusses the need for risk stratification prior to giving chemoimmunotherapy to patients with chronic lymphocytic leukemia (CLL).

Risk stratification can inform which patients are most likely to respond to chemoimmunotherapy, says Abedin. As such, it is important to obtain molecular results regarding 11q deletions, 17p loss or mutations, and IGHV mutational status, which can all be prognostic indicators of response to chemoimmunotherapy, Abedin says.

Chemoimmunotherapy remains the standard frontline treatment regimen for up to half of patients with CLL, so ensuring patients are risk stratified before treatment initiation is important, concludes Abedin.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies
Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

Jun 18th 2025 - Jun 19th 2026

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity